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Peripheral administration of lipopolysaccharide (LPS), a potent bacterial endotoxin, can cause a variety of central effects, including
production of cytokines and cyclooxygenases in the brain, as well as peripheral increases in corticosterone. These, in turn, may contribute
to neuroimmune-induced neurocognitive deficits. We show here LPS causes deficits in hippocampal-dependent spatial learning in the
water maze but that treatment with ibuprofen, a broad-spectrum cyclooxygenase inhibitor, reverses the deficits induced in spatial learning
by LPS. We also show that LPS causes an impairment in the induction of long-term potentiation in the dentate gyrus in vivo, a major
contemporary model of learning and memory. No differences were found in corticosterone levels in trunk blood but we find a decrease in
brain-derived neurotrophic factor (BDNF) expression in LPS group compared to saline controls. Paradoxically compared to the
behavioral findings treatment with ibuprofen does not attenuate the LPS-induced impairment in LTP or BDNF concentration in tetanized
tissue.
D 2005 Elsevier B.V. All rights reserved.
Theme: Endotoxins
Topic: Synaptic plasticity and learning
Keywords: Cyclooxygenase inhibition; Lipopolysaccharide; Long-term potentiation1. Introduction
Lipopolysaccharide (LPS), a potent bacterial endotoxin,
produces a wide range of non-specific behavioral effects
collectively termed dsickness behaviorsT [18]. Such beha-
viors include a reduction in activity and exploration,
decreased social interaction, fever, a reduction in consump-
tion of food and drink, hypersomnia, activation of the
hypothalamic–pituitary–adrenal axis and increased sympa-
thetic activation [15,24,27]. The exact mechanism of action
by LPS in the central nervous system (CNS) remains
unclear; it was previously thought to act primarily through0006-8993/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.brainres.2005.01.035
T Corresponding author. Fax: +353 1 7084767.
E-mail address: Sean.Commins@may.ie (S. Commins).the release of cytokines [10], which activate a chain of
immune and endocrine responses [11], including increases
in corticosterone. Now, evidence suggests that LPS activates
Toll-like receptor 4 (TLR-4) in the circumventricular organs
and result in a NFKappaB-dependent induction of proin-
flammatory cytokines [19].
The pro-inflammatory enzyme cyclooxygenase is found
in two isoforms in neurons (COX1 and 2); LPS induces the
expression of COX2 and leads to the production of
prostaglandins (PGs) [24,32]. Inhibition of the COX path-
way of arachidonic acid (AA) metabolism has been the
accepted explanation for the anti-inflammatory, analgesic,
and antipyretic properties of non-steroidal anti-inflamma-
tory drugs (NSAIDs) [8]. Both COX isoforms are expressed
in hippocampal neurons [4,31].(2005) 231–237
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types of learning and memory [30]. Recent evidence
suggests that LPS may disrupt certain mnemonic processes:
acute administration of LPS prior to training impairs
contextual fear conditioning, a hippocampal-dependent
learning paradigm [27], while a chronic infusion of LPS
has been found to impair spatial memory [16,17]. Further-
more, administration of IL-1 beta impairs performance of
rats in the Morris water maze, another hippocampal-
dependent learning task [25]. Long-term potentiation
(LTP) of synaptic transmission is a popular model of the
biological processes that may underlie memory [2,3]. LTP is
readily induced in the hippocampus; blocking LTP causes
impairment on the water maze task [23]. LPS inhibits LTP
in the rat dentate gyrus in vitro [9] and in the CA1-
subiculum pathway in vivo [7].
We have recently shown that a broad-spectrum cyclo-
oxygenase inhibitor, ibuprofen (IBU), can affect both
synaptic plasticity and hippocampal-dependent learning
and that these deficits can be reversed by increasing
endogenous brain-derived neurotrophic factor (BDNF,
[29]). BDNF plays a critical role in the survival and
growth of neurons. High levels of this neurotrophin are
found in the hippocampus and have been implicated in
hippocampal-dependent learning. Recent studies have
found that BDNF also regulates synaptic plasticity; more
specifically, the exogenous application of BDNF enhances
synaptic transmission in hippocampal neurons and enhan-
ces LTP [19]. BDNF expression is increased in the
hippocampus during spatial learning tasks, lending further
support for its role in learning and memory [13,14]. Little
research has been performed on the effects of LPS on
BDNF expression, and the existing research is conflicting.
Elkabes et al. [12] found BDNF expression was unaltered
in the rat brain in the presence of LPS, whereas Miwa et
al. [22] found that LPS stimulated the synthesis of BDNF.
Shaw et al. [28] injected rats with LPS intraperitoneally
and trained them in the water maze. A single injection of
LPS impaired escape latency in both the acquisition and
retention phases of the study, whereas a daily injection of
LPS did not significantly impair acquisition or retention.
No significant differences in BDNF expression were
found between the three groups. LPS, by triggering
cytokine expression, may contribute to neuropathological
cell death via COX expression. It follows that by
blocking the LPS-induced COX expression, there should
be a reversal of the observed LPS-produced learning
deficit.
The experiments presented here examine the effects of
LPS on hippocampal-dependent spatial learning, LTP and
BNDF expression in the dentate gyrus of the hippocampal
formation. We also investigate the pharmaco-therapeutic
effects of ibuprofen (a broad-spectrum COX inhibitor) [8]
on LPS-treated animals. We hypothesize that ibuprofen will
attenuate the LPS-induced learning deficit in both the water
maze and LTP. We expect that by blocking LPS-inducedCOX expression, that the LPS-produced learning deficit
should be reversed.2. Methods and materials
2.1. Animals
Adult male Wistar rats (BioResources Unit, University of
Dublin; weight: 200–300 g), pair-housed in a temperature-
controlled laminar airflow cupboard, on a 12:12 light/dark
cycle with free access to food and water, were used. Rats
were pair-housed and maintained on a 12:12 light/dark
cycle. Guideline for the maintenance and experimentation of
animals conformed to the Department of Health (Ireland)
guidelines and European directive 86/609/EC. Every effort
was made to minimize the suffering and the number of
animals used.
2.2. Behavioral experiments
Rats were randomly assigned to one of 4 groups (n =
6/group):
(1) Single LPS injection: LPS (i.p. 250 Ag/kg obtained
from Escherichia coli; (L-2630; 100 mg) Sigma,
USA) injected once on the first day of the acquisition
phase 4 h before training.
(2) LPS and ibuprofen co-administration injection: Ani-
mals were pre-treated with ibuprofen (i.p. 30 mg/kg
obtained from Sigma, USA) 1 h before the LPS (i.p.
250 Ag/kg) injection; animals were tested 4 h after the
LPS injection.
(3) Saline control: Saline (i.p. 0.9%) injected once on
the first day of the acquisition phase 4 h before
training.
(4) Ibuprofen-only: Ibuprofen (i.p. 30 mg/kg obtained
from Sigma, USA) was injected once on the first day
of the acquisition phase 1 h before training.2.2.1. Water maze training
All water maze experiments were conducted using an
automated computerized digital tracking system (Etho-
Vision, Noldus, Netherlands), using standardized protocols
[28]. The water maze was a black circular pool (2 m
diameter, 35 cm deep; water, 20 F 1 8C) filled to 31 cm.
Rats could escape the water by climbing on to a hidden
platform (29 cm  9 cm). The hidden platform was placed
in the northeastern quadrant of the pool and submerged 2
cm below the water surface so it was invisible at water
level; the location of the platform was fixed during the
experiment. Distal cues were standard room objects (e.g.,
doors, shelving, and curtains). Rats received five trials per
day for 5 days, where they had to search for the hidden
platform. The rat was allowed 60 s to find the platform;
otherwise, the rat was led to the platform by the researcher.
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interval was 5 s. Following the 5 days training, animals
were allowed to rest for a further 3 days. Retention was
examined by a further 3 days of trials.
2.3. Electrophysiological procedures
Rats were randomly assigned to one of 4 groups (n =
6/group).
(1) Single LPS injection: LPS (i.p. 250 Ag/kg obtained
from Escherichia coli; (L-2630 100 mg): Sigma
Chemical, St. Louis, MO, USA) injected 4 h before
anesthesia.
(2) LPS and ibuprofen co-administration injection: Ani-
mals were pre-treated with ibuprofen (i.p. 30 mg/kg
obtained from Sigma, USA) 1 h before the LPS (i.p.
250 Ag/kg) injection; animals were anesthetized 4 h
after the LPS injection.
(3) Saline control: Saline (i.p. 0.9%) was injected 1 h
before anesthesia.
(4) Animals were pre-treated with ibuprofen (i.p. 30 mg/
kg obtained from Sigma, USA) 4 h before anesthesia.2.3.1. Electrophysiology
All electrophysiological experiments were conducted in
vivo (see Ref. [5] for details). In brief stimulating
electrodes (8.1 posterior to Bregma and 4.4 mm lateral)
were aimed at the perforant path and recording electrodes
(3.9 mm posterior to Bregma and 2.5 mm lateral) at DG
[26]. Signals were filtered (0.1 Hz–1 kHz) and amplified
(100; DAM-50 differential amplifier, WPI, UK). Record-
ings were digitized online using a PC connected to a CED-
1401 interface (CED, UK). Electrodes were slowly
lowered to a depth of 2.5 mm; test stimuli were admi-
nistered during electrode movement at 0.05 Hz. The final
depths were adjusted until maximal fEPSPs were obtained;
electrodes were allowed to settle for 10 min before
recordings were conducted at half-maximum fEPSPs
(using individually determined input–output curves). Field
EPSPs are expressed as percent baseline slope (mean F
SEM).
LTP was induced by high-frequency stimulation (HFS:
10 trains of 20 stimuli at 200 Hz, inter-train interval of 2 s;
[6]), after which baseline stimulation was resumed and
fEPSPs recorded for 30 min.
2.4. Measurement of BDNF and blood corticosterone
After each experiment, the animals were stunned,
decapitated quickly and the brain was removed. The
hippocampus was dissected out bilaterally according to
standard methods [13,14,28] and the DG was isolated,
chopped and stored (70 8C) pending subsequent bio-
chemical analysis. Concentrations of BDNF were deter-
mined using ELISA.2.4.1. BDNF enzyme-linked immunosorbent assay protocol
(BDNF Emaxk ImmunoAssay System; Promega, UK, Ltd.)
Slices of dentate gyrus were preincubated in 250 Al
Krebs solution containing 2 mM CaCl2 for 3 min, and the
supernatant was removed and discarded. This step was
repeated in a volume of 100 Al, and at the end of the 3-min
incubation samples were centrifuged at 1000  g for 3 min
and the supernatant was retained. This step was repeated
in the presence of 40 mM KCl to depolarize the slices
and supernatant was retained. Both samples of supernatant
were stored at 70 8C for later analysis of BDNF by
two-site immunoassay. BDNF concentration was deter-
mined in the supernatant. Dentate gyri were homogenized
in ice-cold Krebs solution 25 times, centrifuged and the
supernatant retained. Protein was assessed and samples
were diluted to give equal protein concentrations and
stored at 80 8C. Ninety-six well plates were coated with
100 Al anti-BDNF monoclonal antibody diluted (1:1000)
in 0.025 M carbonate-bicarbonate buffer. Plates were
covered, incubated overnight at 4 8C and plates were
subjected to interceding washes to remove excess anti-
body. Plates were blocked for non-specific binding for 1 h
at room temperature and washed (composition of wash
buffer (mM): Tris–HCl, 20; NaCl, 150 containing 0.05%
Tween (v/v); pH 7.6). Samples of dentate gyrus (50 Al),
supernatant (50 Al) or BDNF standards (50 Al; ranging
from 0.0078 to 1 ng/ml) were added to the wells, which
were then covered, incubated for 2 h at room temperature
with shaking, and then incubated overnight at 4 8C, and
washed. Aliquots (100 Al) of anti-human BDNF pAb
(diluted 1:500) were added to the wells, plates were
incubated for 2 h at 37 8C and washed. Aliquots (100 Al)
of anti-immunoglobulin horseradish peroxidase (1:2000
dilution) were added to wells and incubated for 1 h at
37 8C. During this incubation, the enzyme substrate was
prepared. Plates were washed and 100 Al of this substrate
was added to the wells, and incubated for approximately
15 min until a blue color formed in the wells. The
reaction was stopped by the addition of 100 Al of 1 M
phosphoric acid to the wells. Plates were read a 450 nm
in a 96-well plate reader, and BDNF concentrations were
estimated for the standard curve (expressed as ng/mg
protein).
Corticosterone levels were measured by radioimmuno-
assay in trunk blood. The serum was collected on decapi-
tation and then rapidly frozen at 20 8C and stored for
subsequent analysis (DPC, USA; [29]). With this procedure
serum samples are assayed directly, without preparation.
Samples were thawed to room temperature and 50 AL of
either serum or calibrator (ranging from 0 to 2000 ng/mL
corticosterone) was added to the rat corticosterone AB-
Coated test tubes. These tubes were pre-coated with anti-
bodies to rat corticosterone. 100 mL of 125I Rat Cortico-
sterone was added to every tube and incubated for 2 h at room
temperature. The tubes were then decanted and counted for 1
min in a gamma counter. Concentrations were estimated from
K.N. Shaw et al. / Brain Research 1038 (2005) 231–237234the calibrator standard curve and expressed as ng/mL of
corticosterone.
2.5. Statistics
Behavioral data were analysed using repeated measures
ANOVA; BDNF ELISA values and corticosterone levels
were analysed using a one-way ANOVA; a value of P b
0.05 was considered to be significant. Between groups post
hoc comparisons were made using Tukey’s method (P b
0.05). Dependent t tests were used to analyze the electro-
physiological data within group and ANOVA were used to
compare across groups.3. Results
3.1. Water maze training and retention analysis
3.1.1. Direct Swim analysis
A direct swim pathway to the hidden platform was
defined (see Ref. [28], this is thought to be a more
stringent measure of learning). The percentage time
animals spent in this pathway (30 cm wide from the start
position to the platform, see Fig. 1a inset) was used to
measure the most direct route. Overall main effects within
groups were found (Days 1–5: F(4,384) = 46.993, P b
0.001; Days 9–11: F(2,160) = 11.42, P b 0.001); post hoc
testing did not show any significant differences across days
suggesting that all 4 groups were able to learn the water
maze task. However, further analysis revealed that the LPS
group and the ibuprofen group failed to use the most direct
route to find the hidden platform compared to the other
groups. On day 1, the LPS group was significantly worseFig. 1. (a) Percentage of time spent in the direct route to the platform for all groups
taken from the last days of acquisition (day 5) for each group (n = 6/group; *Pthan the LPS and ibuprofen groups (P b 0.01); both the
saline controls and the LPS and ibuprofen used the most
direct route to find the platform on day 4 compared to the
LPS and ibuprofen-only groups. Fig. 1b shows representa-
tive swim paths taken from each group on day 5. Similarly,
the LPS-only group did not take the most direct route to
the platform during the retention phase of the task. In
addition, no significant difference in dentate BDNF
concentration or blood corticosterone concentration was
found between the groups on the final day (day 11; data
not shown).
3.2. Electrophysiological results
3.2.1. Effect of LPS, LPS and ibuprofen and saline on
synaptic plasticity
In saline-treated animals, LTP was successfully induced.
Field EPSPs remained potentiated for at least 30 min as
indicated by the change in fEPSP slope which stood at
139.27 F 10.8%, 146.39 F 9.3%, 150.5 F 9.5% of
baseline at 5, 15 and 30 min post-HFS, respectively (see
Fig. 2). The mean percentage increase in fEPSP response
for the final 10 min of the recording period stood at 110 F
0.44%, 111 F 0.58% and 103.7 F 0.41% for the LPS, LPS
and ibuprofen, and ibuprofen-only groups, respectively. An
overall significant difference was found between the four
groups for last 10 min of the recording period (ANOVA:
F(3,39) = 53.095, P b 0.001). Post hoc tests showed that
the mean increase of the fEPSP response of the saline
group was significantly higher when compared to the other
three groups.
BDNF concentration was determined in the dentate gyrus
from all animals in each of the four groups. A 2  4 way
ANOVA was used. Stimulation (stimulated Vs unstimu-across the acquisition and retention periods. (b) Representative swim paths
b 0.05; **P b 0.01).
Fig. 2. Percentage change in amplitude of fEPSPs after HFS in all groups.
Fig. 3. (a) Mean concentration of BDNF in dentate gyrus from tetanized and untetanized tissue; (b) Average corticosterone levels from animals in the above
experiment (n = 6/group; *P b 0.05; **P b 0.01).
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(saline, LPS, LPS and Ibuprofen, and Ibuprofen-only) as the
second between group condition. These analyses revealed a
non-significant effect for stimulation (F = 0.85, df = 1.48,
P N 0.05), a non-significant interaction effect (F = 0.242;
df = 3.48, P N 0.05). However there was a significant effect
for group (see Fig. 3a; F = 29.54, df = 3.48, P b 0.001).
Subsequent post hoc analysis revealed that the saline group
had significantly higher concentrations of BDNF and
compared to the other three groups. In addition, the LPS-
only group had significantly higher BDNF concentrations
when compared to the LPS and ibuprofen group.
Corticosterone levels were determined from trunk blood
taken immediately after recording. Fig. 3b shows that no
significant differences were found between the four groups
(ANOVA: F(3,19) = 3.211, P N 0.05).4. Discussion
We investigated the neuroprotective effects of cyclo-
oxygenase inhibition (using the broad-spectrum cycloox-
ygenase inhibitor, ibuprofen) in LPS-treated animals in
relation to both spatial learning and LTP induction. We were
particularly interested to investigate if ibuprofen attenuated
the LPS-induced spatial learning and LTP blockade. We
found that the LPS and ibuprofen co-treatment group
learned the task better than the LPS-only group, as shown
by the direct swim route analysis. We also found that there
were no differences in BDNF concentration or cortico-
sterone levels between the different treated groups and
controls.
The set of experiments presented here demonstrate that
peripheral stimulation by the endotoxin LPS impairs long-
term potentiation in the dentate-gyrus in vivo. These
findings replicate our own previous results in the CA1-
subiculum projection [7] and confirm the findings by
Cunningham et al. [9] who found that LPS also blocks
LTP in the dentate gyrus in vitro. We had suggested in the
introduction that this LPS-induced blockade of LTP may
result via an increase in COX expression. If this were the
case, then co-administration of LPS and the COX inhibitor
ibuprofen would attenuate the LPS-induced deficit in LTP.
However, we found that this did not occur and that LPS and
ibuprofen-treated group also impaired LTP induction. It is
possible that LPS mediates its effect on synaptic plasticity
via an alternative mechanism to that used during spatial
learning and memory. It is also known that the inflammatory
cytokines are expressed in the hippocampus during seizures
and Alzheimer’s disease [1] suggesting that these cytokines
affect normal hippocampal functioning both at the cellular
and behavioral level. In addition to this, IL-1 beta has been
shown to inhibit the induction of LTP in areas CA1 and
CA3 of the hippocampus but does not impair spatial
navigation [25]. An alternative explanation of our findings
may be accounted by a complicated interaction effectbetween COX, BDNF and synaptic plasticity. We show
that the IBU-only group also seemed to cause a deficit in
LTP, as seen previously (see Ref. [29]). Therefore, any
effect of COX inhibition on the blockade of LTP by LPS
may be masked by the deficit observed with the IBU group
alone.
No differences were found in corticosterone levels
between the groups, suggesting that the inhibition of LTP
was not due to increased circulating glucocorticoids.
Furthermore, we report that the saline-controls have
increased BDNF levels compared to the other groups. We
have previously shown that spatial learning increases BDNF
concentration and others have found an increase in BDNF in
tetanized tissue [14]. We, thus, would expect to find an
increase in BDNF in the saline-controls. As LTP was
inhibited in the other groups, we would not expect an
increase in BDNF. Interestingly, there was a difference in
BDNF concentration between the LPS-only group and the
LPS and ibuprofen group perhaps giving credence to the idea
of a complex interaction effect between the COX enzyme
and neurotrophin expression.
There was no difference in BDNF concentration between
the water maze-trained groups yet there was a difference
between the tetanized groups. It appears that the BDNF
increase that facilitates learning and/or LTP is time depend-
ent. The tissue analysed from the water maze-trained
animals was taken 11 days after the initial LPS and
ibuprofen administration, whereas the tetanized dentate gyri
were taken 6 h following LPS injection. The BDNF increase
after HFS suggests that BDNF-dependent LTP is needed for
the encoding of memory and once this process had finished,
BDNF levels gradually return to baseline over a period of
days. This explains the lack of BDNF differences in the
spatially trained animals as, by day 11, the memory had
been encoded and consolidated, returning BDNF levels to
baseline.
There is very little research investigating the interaction
between COX regulation and neurotrophins. The stimula-
tion of glutamate receptors by kainic acid increases COX2
levels in rat hippocampus [21]. Glutamate also stimulates
NMDA receptors that permit an influx of Ca2+ into the
post-synaptic cell. This Ca2+ influx stimulates a cascade of
reactions required for LTP, one end product being BDNF
transcription [2,14]. Manev et al. [21] reported a link
between increased glutamate, Ca2+ and COX2 activation.
This finding suggests a possible relationship between the
Ras and phospholipase A2-arachidonic acid pathways.
Furthermore, c-fos is rapidly induced by hippocampal
NMDA activation and this NMDA response is blocked by
a COX inhibitor [20]; this response must involve events in
the nucleus, suggesting a COX-dependent signal linking
receptor activation and gene expression. The stimulation of
COX by LPS activates the COX-PG pathway thus reducing
the available COX required for the stimulation of plastic
related pathways. By inhibiting the LPS induced produc-
tion of COX with a NSAID and thus blocking the
K.N. Shaw et al. / Brain Research 1038 (2005) 231–237 237stimulation of the AA-PG pathway, plasticity-dependent
Ca2+ may stimulate constituent COX levels required for
further changes.Acknowledgments
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